Tobias Bollenbach
Overview
Explore the profile of Tobias Bollenbach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1695
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Mitosch K, Rieckh G, Bollenbach T
Cell Syst
. 2017 Mar;
4(4):393-403.e5.
PMID: 28342718
Antibiotics elicit drastic changes in microbial gene expression, including the induction of stress response genes. While certain stress responses are known to "cross-protect" bacteria from other stressors, it is unclear...
22.
Lukacisinova M, Bollenbach T
Curr Opin Biotechnol
. 2017 Mar;
46:90-97.
PMID: 28292709
The rising prevalence of antibiotic resistant bacteria is an increasingly serious public health challenge. To address this problem, recent work ranging from clinical studies to theoretical modeling has provided valuable...
23.
Schwarz J, Bierbaum V, Merrin J, Frank T, Hauschild R, Bollenbach T, et al.
Sci Rep
. 2016 Nov;
6:36440.
PMID: 27819270
Cellular locomotion is a central hallmark of eukaryotic life. It is governed by cell-extrinsic molecular factors, which can either emerge in the soluble phase or as immobilized, often adhesive ligands....
24.
Michalko J, Dravecka M, Bollenbach T, Friml J
F1000Res
. 2015 Dec;
4:1104.
PMID: 26629335
The Auxin Binding Protein1 (ABP1) has been identified based on its ability to bind auxin with high affinity and studied for a long time as a prime candidate for the...
25.
Chevereau G, Dravecka M, Batur T, Guvenek A, Ayhan D, Toprak E, et al.
PLoS Biol
. 2015 Nov;
13(11):e1002299.
PMID: 26581035
The emergence of drug resistant pathogens is a serious public health problem. It is a long-standing goal to predict rates of resistance evolution and design optimal treatment strategies accordingly. To...
26.
Bollenbach T
Curr Opin Microbiol
. 2015 Jun;
27:1-9.
PMID: 26042389
Combining antibiotics is a promising strategy for increasing treatment efficacy and for controlling resistance evolution. When drugs are combined, their effects on cells may be amplified or weakened, that is...
27.
Chevereau G, Bollenbach T
Mol Syst Biol
. 2015 May;
11(4):807.
PMID: 25924924
Drug combinations are increasingly important in disease treatments, for combating drug resistance, and for elucidating fundamental relationships in cell physiology. When drugs are combined, their individual effects on cells may...
28.
Bollenbach T, Heisenberg C
Cell
. 2015 Apr;
161(3):431-432.
PMID: 25910201
In animal embryos, morphogen gradients determine tissue patterning and morphogenesis. Shyer et al. provide evidence that, during vertebrate gut formation, tissue folding generates graded activity of signals required for subsequent...
29.
Mitosch K, Bollenbach T
Environ Microbiol Rep
. 2015 Mar;
6(6):545-57.
PMID: 25756107
Antibiotics affect bacterial cell physiology at many levels. Rather than just compensating for the direct cellular defects caused by the drug, bacteria respond to antibiotics by changing their morphology, macromolecular...
30.
Kicheva A, Bollenbach T, Ribeiro A, Valle H, Lovell-Badge R, Episkopou V, et al.
Science
. 2014 Sep;
345(6204):1254927.
PMID: 25258086
Development requires tissue growth as well as cell diversification. To address how these processes are coordinated, we analyzed the development of molecularly distinct domains of neural progenitors in the mouse...